FCGR3A and systemic lupus erythematosus: Mutations and aberrant expression of FCGR3A have been reported to contribute to increased susceptibility to several inflammatory and immune diseases, including systemic lupus erythematosus, recurrent infectious diseases, and childhood chronic immune thrombocytopenic purpura45–47.